
Moving Towards ICH Q5A(R2): Use of Next Generation Sequencing for Viral Safety Testing of Biotechnology Products

Speaker Presentation Charbaut Taland Elodie Merck & Co., Inc. 2023
Moving Towards ICH Q5A(R2): Use of Next Generation Sequencing for Viral Safety Testing of Biotechnology Products
Moving Towards ICH Q5A(R2): Use of Next Generation Sequencing for Viral Safety Testing of Biotechnology Products